HealthQuill USFDA
Anglo-Swedish AstraZeneca Inc., and US-based Ionis Pharmaceuticals, announced the FDA has granted its nod for Wainua drug to treat nervous system impairment.
Drugs Health Pharma

USFDA clears AstraZeneca-Ionis’ drug for nervous system impairment

HQ Team December 22, 2023: Anglo-Swedish AstraZeneca Inc., and US-based Ionis Pharmaceuticals, announced the FDA has granted its nod for Wainua drug to.

Read More
The FDA has seized “thousands of units” of counterfeit weight-loss injection Ozempic which have no information about the drug’s identity, quality or safety.
Drugs Health Pharma

FDA starts crackdown against fake Ozempic weight-loss drug 

HQ Team December 22, 2023: The FDA has seized “thousands of units” of counterfeit weight-loss injection Ozempic which have no information about the.

Read More
The USFDA has approved Calliditas Therapeutics’ oral drug to treat loss of kidney function in adults with primary immunoglobulin A nephropathy (IgAN) and at risk of disease progression.
Drugs Health Pharma

Sweden’s Calliditas gets FDA nod for oral drug to treat kidney loss function

HQ Team December 21, 2023: Sweden’s Calliditas Therapeutics has got the USFDA green light for its oral drug to treat loss of kidney.

Read More
The US drug regulator has termed its Class I recall of Philips magnetic resonance systems as the “most serious” type.
Drugs Health Pharma

Recall of Philips imaging devices ‘most serious’: USFDA says

HQ Team December 21, 2023: The US drug regulator has termed its Class I recall of Philips magnetic resonance systems as the “most.

Read More
Merck announced it has got USFDA approval for its belzutifan drug, branded as Welireg, to treat an advanced form of kidney cancer.
Drugs Health Pharma

USFDA green lights Merck’s drug to treat advanced kidney cancer 

HQ Team December 15, 2023: Merck announced it got USFDA approval for its belzutifan drug, branded as Welireg, to treat an advanced form.

Read More
The USFDA has approved two treatments for sickle cell disease, one of them the first in the US based on gene-editing technology.
Drugs Health Pharma

US drug regulator approves two treatments for sickle cell disease 

HQ Team December 8, 2023: The USFDA has approved two treatments for sickle cell disease, one of them the first in the US.

Read More
The US Food and Drug Administration (USFDA) is assessing the potential for failures in plastic syringes manufactured in China.
Drugs Health Pharma

FDA probes failure of syringes made in China for possible breakages

HQ Team December 1, 2023: The US Food and Drug Administration (USFDA) is assessing the potential for failures in plastic syringes manufactured in.

Read More
The USFDA is probing cancer therapies of Gilead Sciences, Johnson & Johnson and Novartis following reports of malignancies in patients who received treatment.
Drugs Health Pharma

FDA probing T cell cancer therapies of Gilead Sciences, Novartis, J & J

HQ Team November 29, 2023: The USFDA is probing cancer therapies of Gilead Sciences, Johnson & Johnson and Novartis following reports of malignancies.

Read More
The USFDA has officially pulled out of its membership of the Global Harmonization Working Party (GHWP), an organization currently chaired by China for the standardization of medical devices, due to a divergence of views.
Drugs Medical Pharma

FDA pulls out of 33-member medical devices body as differences emerge

HQ Team November 28, 2023: The USFDA has officially pulled out of its membership of the Global Harmonization Working Party (GHWP), an organization.

Read More
The Food and Drug Administration (FDA) has green-lighted Astellas Pharma’s prostrate cancer drug Xtandi five weeks ahead of the scheduled approval date.
Drugs Health Pharma

Astellas’ prostate cancer drug for metastasis-free survival gets nod

HQ Team November 18, 2023: The Food and Drug Administration (FDA) has green-lighted Astellas Pharma’s prostrate cancer drug Xtandi five weeks ahead of.

Read More